AOD 9604 clinical trials showed a tolerability profile statistically indistinguishable from placebo
If you are taking the levocarnitine blend specifically for its fat-oxidation benefits, note that L-carnitine works best when there are fatty acids available to transport
Similar content being viewed by others Subjects Introduction Discovery of the so called incretin effect, where ingested glucose leads to enhanced insulin release compared to intravenous glucose administration, revealed the existence of insulin release factors in the gut 1
That's different from gastroparesis, which is a chronic condition where the stomach doesn't empty properly even without medication
There are several types of GLP medications that engage different types of glucagon receptors, giving them different effects in different people: Single receptor agonists (GLP-1 only): Ozempic, Wegovy, Saxenda Dual receptor agonists (GLP-1 + GIP): Mounjaro, Zepbound Triple receptor agonists (GLP-1 + GIP + glucagon): in development early studies show even greater metabolic effects These medications are changing how we are able to ameliorate obesity, food addiction, insulin resistance, and cardiometabolic risks
In addition, GLP-1 delays stomach emptying, suppresses appetite, inhibits glucagon secretion, and slows glucose production in the liver
